difference between compound semaglutide and wegovy vs Compounded Semaglutide: Key Differences to Know Wegovy vs Compounded Semaglutide: Key

Learn how lifestyle changes can help do that.

Introduction: Obesity is a global epidemic affecting 2.5 billion people and is recognized as the fourth leading cause of global mortality

Discover how the rise of GLP-1 medications is reshaping food retail, influencing portion control, menu design and nutritional priorities across the UK.

In most major obesity trials, GLP-1 therapy was: Escalated to high or maximum tolerated doses Stopped abruptly, not down-titrated Followed by little or no continuation of structured lifestyle support In the STEP-1 extension trial (semaglutide 2.4 mg), participants who discontinued therapy regained approximately two-thirds of their prior weight loss over the following year

The product is formulated to support healthy weight management

With the rising incidence of obesity, there is a growing demand for new therapies which can effectively manage body weight and improve health